Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Enanta Pharmaceuticals (ENTA) Preferred Dividend Payments: 2012-2013

Historic Preferred Dividend Payments for Enanta Pharmaceuticals (ENTA) over the last 1 years, with Mar 2013 value amounting to $1.2 million.

  • Enanta Pharmaceuticals' Preferred Dividend Payments rose 130.48% to $1.2 million in Q1 2013 from the same period last year, while for Mar 2013 it was $16.4 million, marking a year-over-year change of. This contributed to the annual value of $13.7 million for FY2013, which is 6.77% down from last year.
  • Enanta Pharmaceuticals' Preferred Dividend Payments amounted to $1.2 million in Q1 2013, which was down 93.39% from $18.8 million recorded in Q4 2012.
  • Enanta Pharmaceuticals' 5-year Preferred Dividend Payments high stood at $18.8 million for Q4 2012, and its period low was -$4.9 million during Q3 2012.
  • In the last 2 years, Enanta Pharmaceuticals' Preferred Dividend Payments had a median value of $1.2 million in 2013 and averaged $2.5 million.
  • Data for Enanta Pharmaceuticals' Preferred Dividend Payments shows a peak YoY soared of 130.48% (in 2013) over the last 5 years.
  • Enanta Pharmaceuticals' Preferred Dividend Payments (Quarterly) stood at $18.8 million in 2012, then surged by 130.48% to $1.2 million in 2013.
  • Its last three reported values are $1.2 million in Q1 2013, $18.8 million for Q4 2012, and -$4.9 million during Q3 2012.